source
- Capricor secures reprieve as FDA extends DMD cell therapy reviewThe FDA has extended its review of Capricor Therapeutics’ Duchenne muscular dystrophy drug candidate, deferring the decision to review information the biotech submitted after a negative advisory co…Fierce Biotech · 4h ago↗ source
- Roche and Eli Lilly receive FDA clearance for first blood test detecting Alzheimer’s biomarker pTau217Roche and Eli Lilly have secured FDA clearance for a new blood test that measures phosphorylated tau protein pTau217, a marker linked to amyloid plaques in Alzheimer’s disease. The Elecsys pTau217…